Streetbeat News

Products Services

AMPX

Amprius Technologies has signed a development contract with a Fortune 500 company to create a small format custom high-energy SiMaxx pouch cell. This partnership could enhance Amprius's market position and technological capabilities.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:32 pm

FEMY

Femasys has received a second order from its partners in Spain after a successful commercial launch of its FemaSeed infertility treatments in Europe. This indicates growing demand and potential market expansion for Femasys' products.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:32 pm

GILD

Gilead Sciences has signed royalty-free licensing agreements with six generic manufacturers to produce and supply lenacapavir for HIV prevention and treatment in 120 low-income countries. Gilead will provide the drug at no profit until generics can meet demand.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:31 pm

ASNS

Actelis Networks has received an expansion order worth over $300,000 for a major Italian national transportation infrastructure project. This order signifies a growing demand for Actelis' solutions in international markets.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:31 pm

BP

IMO

MPC

MRO

OXY

SHEL

TTE

Energy stocks are experiencing a rise in share prices due to an increase in oil prices following Iran's missile attack on Israel.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:28 pm

BNO

UCO

USO

Oil prices are rising due to supply uncertainty following Iran's attack on Israel.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:23 pm

VCYT

Veracyte, Inc. presented new data from the VANDAAM trial at ASTRO 2024, showing that its Decipher Prostate Genomic Classifier accurately predicts aggressive prostate cancer in African American men. This test offers an improvement over clinical factors alone in guiding treatment decisions for this disproportionately affected population.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:23 pm

SOFI

SoFi has launched DSP2.0 in collaboration with PrimaryBid to enhance U.S. IPOs and capital raises, aiming to provide individual investors with better access to public offerings.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:17 pm

SCPX

Scorpius Holdings, Inc (NYSE American: SCPX) has been selected to join the Medical CBRN Defense Consortium, which focuses on developing medical countermeasures against CBRN threats. This partnership will allow Scorpius to contribute its expertise to advance national security technologies.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:17 pm

ATYR

aTyr Pharma announced the publication of a study in the European Respiratory Journal showing the efficacy of efzofitimod in treating pulmonary sarcoidosis. The study demonstrated a significant reduction in relapse rates for patients on therapeutic doses compared to subtherapeutic doses.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:15 pm